Bharangi

Clerodendrum serratum contains flavonoids (hispidulin, apigenin, scutellarein), phenylethanoid glycosides (acteoside/verbascoside), and triterpenoids (oleanolic acid, clerodermic acid) that exert antioxidant, anti-inflammatory, and mast cell-stabilizing effects through free radical scavenging, enzyme inhibition, and modulation of oxidative stress markers. In an ovalbumin-sensitized murine asthma model, oral root extract at 200 mg/kg significantly reduced total cells and eosinophils in bronchoalveolar lavage fluid (p<0.001), providing the most quantitatively documented preclinical evidence for its traditional use in respiratory conditions.

Category: Southeast Asian Evidence: 1/10 Tier: Preliminary
Bharangi — Hermetica Encyclopedia

Origin & History

Clerodendrum serratum is native to tropical and subtropical regions of South and Southeast Asia, including India, Sri Lanka, Vietnam, and parts of China, where it grows in moist deciduous forests, forest margins, and scrublands at low to mid elevations. In India, it is most prevalent in the Western Ghats, Eastern Ghats, and Himalayan foothills, thriving in humid, well-drained soils with moderate shade. The plant has been cultivated near villages and in home gardens in Vietnam and India for centuries due to its medicinal importance in Ayurvedic and traditional Vietnamese pharmacopoeia.

Historical & Cultural Context

Clerodendrum serratum, known as Bharangi in Sanskrit, occupies a prominent position in classical Ayurvedic medicine, referenced in the Charaka Samhita, Sushruta Samhita, and Ashtanga Hridayam (collectively the Brihat Trayi) as a key herb in formulations for shwasa (asthma), kasa (cough), jwara (fever including typhoid), and prameha (metabolic disorders). In Vietnamese traditional medicine, the plant—referred to locally in the context of cough remedies—has been used as decoctions of roots and leaves, reflecting parallel ethnopharmacological knowledge development across South and Southeast Asia independently of Ayurvedic classification. The genus name Clerodendrum derives from the Greek kleros (chance) and dendron (tree), reflecting historical uncertainty about its properties, while the Ayurvedic name Bharangi connotes the plant's role as a carrier or supporter of respiratory function. The roots are the primary officinal part in both Ayurvedic and Vietnamese traditions, prepared predominantly as water decoctions or expressed juice, sometimes combined with ginger or long pepper (Piper longum) to enhance bioavailability and warming properties in cold-type respiratory conditions.

Health Benefits

- **Respiratory and Anti-Asthmatic Support**: Root extracts stabilize mast cells and reduce eosinophil infiltration in bronchoalveolar lavage fluid at 200 mg/kg (p<0.001 in OVA-sensitized mice), corroborating its Ayurvedic use for asthma and cough; the flavonoid hispidulin is implicated in suppressing airway inflammation.
- **Antioxidant Activity**: Methanolic root extracts demonstrate DPPH radical scavenging with an IC50 of 175 μg/ml (vs. 137 μg/ml for ascorbic acid reference), with dose-dependent reducing power observed across 20–120 μg/ml; acteoside and hispidulin are primary contributors to this activity.
- **Hepatoprotective Effects**: Leaf extract at 200 mg/kg orally reduced elevated liver enzymes (ASAT, ALAT, SGOT, SGPT, ALP) and bilirubin in hepatotoxicity animal models, suggesting protection against chemically induced hepatic damage through antioxidant and anti-inflammatory mechanisms.
- **Anti-Inflammatory and Immunomodulatory Action**: Phenolics including verbascoside and serratagenic acid inhibit pro-inflammatory enzymes and reduce oxidative mediators; the plant modulates cellular immune parameters by decreasing total inflammatory cell counts in pulmonary lavage fluid in preclinical models.
- **Potential Anti-Cancer Activity**: Animal studies report improved lifespan, normalized hematological parameters (RBC, WBC, hemoglobin), and improved biochemical markers (ALAT, ASAT) in tumor-bearing models; triterpenoids such as oleanolic acid are known to exert anti-proliferative effects via apoptosis induction in multiple cancer cell lines.
- **Neuroprotective and Adaptogenic Properties**: Bioactive flavonoids in C. serratum modulate monoaminergic neurotransmission and reduce central oxidative stress, suggesting potential utility in stress-related neuropsychiatric conditions aligned with its Ayurvedic classification as a rasayana (adaptogen).
- **Antimicrobial Activity**: Flavonoids (apigenin, pectolinarigenin) and phenolics (acteoside) exhibit broad-spectrum antimicrobial effects in vitro, providing a pharmacological rationale for traditional applications in syphilis, typhoid, and infected wounds.

How It Works

The antioxidant mechanism involves direct free radical quenching by phenolic hydroxyl groups in hispidulin, acteoside, and scutellarein, alongside upregulation of endogenous antioxidant enzymes superoxide dismutase (SOD) and catalase (CAT) and reduction of malondialdehyde (MDA), a lipid peroxidation biomarker. Anti-inflammatory activity is mediated through mast cell membrane stabilization—inhibiting degranulation and histamine release—as well as inhibition of pro-inflammatory enzymes (likely COX and LOX pathways, consistent with flavonoid pharmacology), resulting in reduced eosinophil and total cell counts in pulmonary tissues. Apigenin and hispidulin are reported to bind benzodiazepine receptor sites at the GABA-A receptor complex, contributing to central nervous system modulation and anxiolytic-like effects observed in preclinical behavioral models. Triterpenoids such as oleanolic acid exert anti-proliferative and hepatoprotective effects by modulating NF-κB signaling, inducing mitochondria-dependent apoptosis in tumor cells, and normalizing hepatic enzyme leakage through membrane-stabilizing actions on hepatocytes.

Scientific Research

The available evidence for Clerodendrum serratum consists entirely of in vitro assays and preclinical animal studies; no human randomized controlled trials have been published as of the current literature review. The most robust preclinical data come from ovalbumin-sensitized murine asthma models demonstrating statistically significant reductions in BAL fluid cellularity (p<0.001) at 200 mg/kg oral root extract, and from hepatotoxicity models showing enzyme normalization at equivalent doses. Antioxidant characterization has been performed using DPPH, reducing power, and related colorimetric assays with extracts standardized by concentration (50–250 μg/ml) rather than by identified compound content, limiting mechanistic precision. The overall body of research is sparse, largely from Indian and Vietnamese research groups, with methodological heterogeneity and an absence of pharmacokinetic, bioavailability, or toxicokinetic data in humans, placing the ingredient firmly in the preliminary-evidence tier.

Clinical Summary

No human clinical trials have been conducted on Clerodendrum serratum to date; the clinical evidence base is absent, and all outcome data derive from cell-based and rodent experiments. Key preclinical outcomes include significant reduction of airway inflammation markers at 200 mg/kg (p<0.001), hepatoprotective enzyme normalization, tumor-bearing animal survival improvement, and in vitro antioxidant IC50 values. While these findings are directionally consistent with traditional Ayurvedic indications for respiratory, hepatic, and inflammatory conditions, effect sizes cannot be extrapolated to human therapeutic doses without clinical translation studies. Confidence in clinical efficacy remains very low due to the complete absence of Phase I, II, or III trial data, and further research including dose-finding, safety, and efficacy studies in humans is required before any therapeutic claims can be substantiated.

Nutritional Profile

Clerodendrum serratum is not used as a dietary staple and therefore lacks a conventional macronutrient or micronutrient profile; its significance lies entirely in its phytochemical constituents rather than caloric or nutritional contribution. Key phytochemicals identified include flavonoids (hispidulin, apigenin, scutellarein, cleroflavone, 7-hydroxyflavanone, pectolinarigenin), phenylethanoid glycosides (acteoside/verbascoside, serratagenic acid), triterpenoids (oleanolic acid, clerodermic acid), sterols (β-sitosterol, γ-sitosterol, stigmasterol), and the sugar alcohol D-mannitol; saponins and tannins are also present as minor constituents. No quantitative concentration data (mg/g dry weight) have been reported for any individual compound in peer-reviewed sources, making precise phytochemical profiling unavailable. Bioavailability is further complicated by the absence of pharmacokinetic studies; the glycosidic nature of acteoside suggests potential hydrolysis by gut microbiota to release aglycone forms, and co-administration with piperine (black pepper) or fat-containing foods may enhance absorption of lipophilic triterpenoids such as oleanolic acid, consistent with traditional Ayurvedic adjuvant practices.

Preparation & Dosage

- **Traditional Decoction (Root Bark)**: 3–6 grams of dried root bark boiled in 200 ml water, reduced to 50 ml, taken orally twice daily in Ayurvedic practice for respiratory and inflammatory conditions; no standardized clinical dose established.
- **Methanolic/Alcoholic Root Extract (Research Form)**: Used at 200 mg/kg body weight orally in animal studies (equivalent to approximately 16 mg/kg when scaled by body surface area to a 60 kg human using standard allometric conversion, yielding ~960 mg/day—unvalidated in humans).
- **Powdered Root**: Referenced in Brihat Trayi Ayurvedic texts as part of compound formulations (e.g., Bharangyadi Kwatha); typical Ayurvedic powder dose is 1–3 g/day combined with honey or warm water.
- **In Vitro Extract Concentrations**: Antioxidant assays utilized 50–250 μg/ml standardized by extract weight; no commercial supplement standardization (e.g., % hispidulin or acteoside) has been established or validated.
- **Timing**: Traditional preparations are administered before meals in Ayurvedic practice; no pharmacokinetic data exist to inform optimized timing in humans.
- **Important Note**: No standardized commercial supplement form exists; all dosage references are either traditional or derived from preclinical research and should not be used as clinical dosing guidance.

Synergy & Pairings

In classical Ayurvedic formulations, Bharangi is traditionally combined with Piper longum (long pepper) and Zingiber officinale (ginger), a combination theorized to enhance bioavailability of polar phenolics through piperine-mediated inhibition of P-glycoprotein efflux and CYP3A4 modulation, while ginger's own anti-inflammatory gingerols may produce additive suppression of airway inflammation. Acteoside and other phenylethanoid glycosides in C. serratum may act synergistically with quercetin or luteolin from co-administered herbs by complementary radical scavenging across different reactive oxygen species (superoxide vs. hydroxyl radical specificity), broadening the antioxidant spectrum. In Vietnamese traditional practice, C. serratum is combined with Adhatoda vasica (Malabar nut) for cough formulations, pairing the mast cell-stabilizing activity of hispidulin with the bronchodilatory alkaloid vasicine, suggesting a mechanistically complementary stack for respiratory indications.

Safety & Interactions

Preclinical animal studies using oral root and leaf extracts at 200 mg/kg have not reported overt acute toxicity, organ damage, or adverse behavioral effects, and hepatoprotective findings in rodent models suggest low acute hepatotoxic risk at studied doses; however, formal acute and chronic toxicity studies with established LD50 values are not available in the published literature. No human safety data, documented adverse events, drug interaction profiles, or maximum tolerated dose studies exist, making it impossible to establish a human safety boundary with confidence. Theoretical interactions should be considered with anticoagulant or antiplatelet drugs (due to flavonoid-mediated COX inhibition), antihypertensive agents (verbascoside has demonstrated blood pressure-lowering effects in animal models), and hepatically metabolized pharmaceuticals (CYP enzyme interactions are unstudied but plausible given the breadth of phenolic constituents). Use during pregnancy and lactation is contraindicated under precautionary principles given the absence of safety data; individuals with known allergies to the Lamiaceae/Verbenaceae family should exercise additional caution.